在关键的グラム阴性细菌和天然排泄抑制剂中产生排泄介导的多药性耐药性
Praveena Nanjan1, Vanitha Bose1
1Department of Biochemistry, School of Life Science, Jss Academy of Higher Education and Research, Longwood Campus, Mysuru Road, Ooty, India.
Current drug research reviews
|January 30, 2024
概括
细菌的多药耐药性是一个日益严重的问题,由排泄驱动. 植物衍生的排泄抑制剂 (EPI) 在恢复抗生素对抗耐药性格拉姆阴性病原体的有效性方面表现有前途.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 微生物中的多药性耐药性 (MDR) 损害了现有的抗生素疗效,需要新的治疗策略.
- 格拉姆阴性细菌中的排泄积极地将抗生素输出,大大导致MDR和治疗失败.
- 抑制这些排泄是克服MDR和重新使细菌对抗生素敏感的关键策略.
研究的目的:
- 审查关键的グラム阴性细菌病原体中流体介导的多药性耐药性.
- 为了检查近几十年来报告的植物源流量抑制剂 (EPI).
- 突出植物性EPI在联合治疗中对抗MDR感染的潜力.
主要方法:
- 对科学数据库 (如PubMed,Scopus) 的文献综述,以研究排泄,格兰阴性细菌中的MDR和植物性EPI.
- 对已识别的EPI报告的作用机制的分析.
- 综合了关于植物EPI对各种格拉姆阴性病原体的疗效的研究结果.
主要成果:
- 溢出是赋予格兰负细菌MDR的主要机制.
- 许多植物衍生化合物表现出排泄抑制活性.
- 在临床前研究中,抗生素与植物性EPI的组合证明了对MDR菌株的增强疗效.
结论:
- 来自植物的排泄抑制剂代表了对抗多药物耐药性的有希望的途径.
- 结合抗生素和EPI可以恢复老药物的有效性,克服耐药性.
- 对植物衍生EPI的进一步研究对于开发针对关键的グラム阴性病原体的新疗法至关重要.
相关概念视频
Carrier-Mediated Transport
435
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
435
Hepatic Drug Clearance: Role of Transporters
59
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
59
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Antibiotic Selection
53.6K
Overview
53.6K
Antimicrobial Proteins
992
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
992


